Header Logo

Connection

ANITA DESWAL to Humans

Back to Details
This is a "connection" page, showing publications ANITA DESWAL has written about Humans.
ANITA DESWAL
Connection Strength
1.543
Humans
  1. Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All. Curr Heart Fail Rep. 2026 Jul 22; 23(1).
    View in: PubMed
    Score: 0.026
  2. Safety of Contemporary Radiation Therapy in Patients With Cardiac Implantable Electronic Devices: Implications for Clinical Practice. J Am Heart Assoc. 2025 Sep 02; 14(17):e042937.
    View in: PubMed
    Score: 0.025
  3. THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARD. Trans Am Clin Climatol Assoc. 2025; 135:43-51.
    View in: PubMed
    Score: 0.024
  4. Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Cardiovasc Drugs Ther. 2025 12; 39(6):1343-1352.
    View in: PubMed
    Score: 0.024
  5. Finding a Signal in the Noise: Exploring Comorbidity Clusters to Personalize Acute Heart?Failure Care. JACC Heart Fail. 2024 Oct; 12(10):1775-1777.
    View in: PubMed
    Score: 0.023
  6. Cardiovascular toxicity of immune therapies for cancer. BMJ. 2024 05 15; 385:e075859.
    View in: PubMed
    Score: 0.023
  7. Moving theory and reality closer together in cardio-oncology training. Eur J Heart Fail. 2024 Apr; 26(4):772-775.
    View in: PubMed
    Score: 0.023
  8. In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med. 2024 03; 177(3):JC31.
    View in: PubMed
    Score: 0.022
  9. In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk. Ann Intern Med. 2023 12; 176(12):JC136.
    View in: PubMed
    Score: 0.022
  10. Noncardiac Comorbidities in Chronic?Heart Failure: More Is Worse, What Else Do We Know? JACC Heart Fail. 2023 10; 11(10):1377-1379.
    View in: PubMed
    Score: 0.021
  11. Catheter Ablation of Atrial Fibrillation in?Persons With HFpEF: We Can All Breathe Easier Now! JACC Heart Fail. 2023 06; 11(6):659-661.
    View in: PubMed
    Score: 0.021
  12. In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding. Ann Intern Med. 2023 04; 176(4):JC43.
    View in: PubMed
    Score: 0.021
  13. COVID-19-Associated Fulminant?Myocarditis: Pathophysiology-Related Phenotypic Variance. J Am Coll Cardiol. 2022 07 26; 80(4):313-315.
    View in: PubMed
    Score: 0.020
  14. Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma. Haematologica. 2022 07 01; 107(7):1555-1566.
    View in: PubMed
    Score: 0.020
  15. Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin. 2022 Jul; 18(3):361-374.
    View in: PubMed
    Score: 0.020
  16. Obesity and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021 Jul; 17(3):345-356.
    View in: PubMed
    Score: 0.019
  17. In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo. Ann Intern Med. 2021 06; 174(6):JC69.
    View in: PubMed
    Score: 0.019
  18. Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry. J Am Heart Assoc. 2021 04 06; 10(7):e018696.
    View in: PubMed
    Score: 0.018
  19. In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization. Ann Intern Med. 2020 11 17; 173(10):JC51.
    View in: PubMed
    Score: 0.018
  20. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep. 2020 10 10; 22(12):171.
    View in: PubMed
    Score: 0.018
  21. Iron deficiency and iron therapy in heart failure and chronic kidney disease. Curr Opin Nephrol Hypertens. 2020 09; 29(5):508-514.
    View in: PubMed
    Score: 0.018
  22. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
    View in: PubMed
    Score: 0.017
  23. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis. 2020 05; 75(5):690-692.
    View in: PubMed
    Score: 0.017
  24. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc. 2020 01 21; 9(2):e013757.
    View in: PubMed
    Score: 0.017
  25. Heart?Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint. J Am Coll Cardiol. 2019 12 10; 74(23):2905-2907.
    View in: PubMed
    Score: 0.017
  26. Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2020 02; 73(2):104-106.
    View in: PubMed
    Score: 0.016
  27. NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF. Ann Intern Med. 2018 08 21; 169(4):JC21.
    View in: PubMed
    Score: 0.015
  28. Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2018 Oct; 14(4):525-535.
    View in: PubMed
    Score: 0.015
  29. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann Intern Med. 2018 05 15; 168(10):JC55.
    View in: PubMed
    Score: 0.015
  30. Observation Versus Inpatient Stay for Heart Failure: Is It Semantics? J Am Heart Assoc. 2018 01 31; 7(3).
    View in: PubMed
    Score: 0.015
  31. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.014
  32. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.014
  33. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker? Curr Atheroscler Rep. 2016 May; 18(5):21.
    View in: PubMed
    Score: 0.013
  34. ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality. Ann Intern Med. 2016 Apr 19; 164(8):JC41.
    View in: PubMed
    Score: 0.013
  35. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.012
  36. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2014 Aug; 20(8):560-8.
    View in: PubMed
    Score: 0.011
  37. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.011
  38. Incident cancer in patients with heart failure: causation or mere association? J Am Coll Cardiol. 2013 Sep 03; 62(10):887-8.
    View in: PubMed
    Score: 0.011
  39. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid Based Med. 2013 Dec; 18(6):226-7.
    View in: PubMed
    Score: 0.011
  40. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.010
  41. Obesity, leptin, and incident heart failure. J Am Coll Cardiol. 2011 Oct 25; 58(18):1878-80.
    View in: PubMed
    Score: 0.010
  42. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.009
  43. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.009
  44. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul; 15(4):331-41.
    View in: PubMed
    Score: 0.009
  45. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med. 2010 Apr-Jun; 36(2):70-6.
    View in: PubMed
    Score: 0.009
  46. Mortality after hospitalization for heart failure in blacks compared to whites. Am J Cardiol. 2010 Mar 01; 105(5):694-700.
    View in: PubMed
    Score: 0.008
  47. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics. 2009 Nov-Dec; 50(6):592-8.
    View in: PubMed
    Score: 0.008
  48. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28; 54(5):422-8.
    View in: PubMed
    Score: 0.008
  49. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol. 2008 May; 23(3):233-40.
    View in: PubMed
    Score: 0.007
  50. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin. 2008 Feb; 26(1):1-14, v.
    View in: PubMed
    Score: 0.007
  51. Anti-angiotensin therapy: new perspectives. Cardiol Clin. 2007 Nov; 25(4):573-80; vi-vii.
    View in: PubMed
    Score: 0.007
  52. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.007
  53. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther. 2007 Apr 15; 25(8):913-24.
    View in: PubMed
    Score: 0.007
  54. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J. 2007 Apr; 153(4):515-22.
    View in: PubMed
    Score: 0.007
  55. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006 Aug; 152(2):348-54.
    View in: PubMed
    Score: 0.007
  56. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. Circulation. 2026 Aug 04; 154(5):e188-e205.
    View in: PubMed
    Score: 0.007
  57. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. J Clin Oncol. 2026 Aug; 44(22):2140-2155.
    View in: PubMed
    Score: 0.007
  58. LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis. Circ Res. 2026 Jul 06; 139(2):e327427.
    View in: PubMed
    Score: 0.007
  59. Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 Jun; 19(6):e019610.
    View in: PubMed
    Score: 0.007
  60. Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. ESC Heart Fail. 2026 May 05; 13(3).
    View in: PubMed
    Score: 0.007
  61. Value of Myocardial Strain in Assessing Cardiac Masses: A Case Report. Methodist Debakey Cardiovasc J. 2026; 22(1):30-33.
    View in: PubMed
    Score: 0.006
  62. Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers. Cancer Med. 2026 Apr; 15(4):e71682.
    View in: PubMed
    Score: 0.006
  63. Arrhythmias and cardiac devices management in oncology patients. Heart Rhythm. 2026 Jul; 23(7):1646-1658.
    View in: PubMed
    Score: 0.006
  64. Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer. Eur J Prev Cardiol. 2026 Mar 13; 33(4):513-525.
    View in: PubMed
    Score: 0.006
  65. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006 Apr 15; 97(8):1228-31.
    View in: PubMed
    Score: 0.006
  66. In HFrEF, adding digitoxin to standard care reduced a composite of death or first worsening HF hospitalization at a median 36 mo. Ann Intern Med. 2026 Jan; 179(1):JC8.
    View in: PubMed
    Score: 0.006
  67. Bayesian Learning to Reduce Cardiac Risk of Patients With Locally Advanced Non-Small Cell Lung Cancer Based on Personalized Radiation Therapy Prescription. Int J Radiat Oncol Biol Phys. 2026 Jul 01; 125(3):949-958.
    View in: PubMed
    Score: 0.006
  68. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.006
  69. Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
    View in: PubMed
    Score: 0.006
  70. Radiation Doses to Cardiac Substructures Predict Elevation in High-sensitivity Cardiac Troponin T Levels in Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2026 Mar 15; 124(4):1124-1136.
    View in: PubMed
    Score: 0.006
  71. Cardiovascular Outcomes in Patients With Cancer Undergoing Cardiac Implantable Electronic Device Implantation. Pacing Clin Electrophysiol. 2025 11; 48(11):1309-1319.
    View in: PubMed
    Score: 0.006
  72. Tackling the Cardio-Kidney-Metabolic Burden in Cancer. Curr Atheroscler Rep. 2025 Sep 15; 27(1):92.
    View in: PubMed
    Score: 0.006
  73. Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025 Nov; 27(11):2152-2167.
    View in: PubMed
    Score: 0.006
  74. Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer. Oncologist. 2025 Aug 04; 30(8).
    View in: PubMed
    Score: 0.006
  75. Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep. 2005 May; 7(3):178-83.
    View in: PubMed
    Score: 0.006
  76. Impacts of Radiation on Metabolism and Vascular Cell Senescence. Antioxid Redox Signal. 2025 07; 43(1-3):92-114.
    View in: PubMed
    Score: 0.006
  77. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. 2025 Aug; 66(8):1437-1446.
    View in: PubMed
    Score: 0.006
  78. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease. J Card Fail. 2005 Apr; 11(3):206-12.
    View in: PubMed
    Score: 0.006
  79. Variation by race in factors contributing to heart failure hospitalizations. J Card Fail. 2005 Feb; 11(1):23-9.
    View in: PubMed
    Score: 0.006
  80. Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal. Eur Heart J. 2025 Jan 16; 46(3):236-249.
    View in: PubMed
    Score: 0.006
  81. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol. 2025 03; 45(3):372-385.
    View in: PubMed
    Score: 0.006
  82. Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. Heart Fail Clin. 2005 Apr; 1(1):25-37.
    View in: PubMed
    Score: 0.006
  83. GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2025 07; 31(7):989-1001.
    View in: PubMed
    Score: 0.006
  84. A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health. Methodist Debakey Cardiovasc J. 2024; 20(5):15-26.
    View in: PubMed
    Score: 0.006
  85. Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol. 2004 Oct 15; 94(8):1003-7.
    View in: PubMed
    Score: 0.006
  86. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025 02; 31(2):415-455.
    View in: PubMed
    Score: 0.006
  87. Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunol Res. 2024 Aug 01; 12(8):964-987.
    View in: PubMed
    Score: 0.006
  88. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. J Nucl Cardiol. 2024 Sep; 39:101909.
    View in: PubMed
    Score: 0.006
  89. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
    View in: PubMed
    Score: 0.006
  90. Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112.
    View in: PubMed
    Score: 0.006
  91. Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association. Circulation. 2024 Apr 16; 149(16):e1113-e1127.
    View in: PubMed
    Score: 0.006
  92. Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol. 2004 Mar 03; 43(5):778-84.
    View in: PubMed
    Score: 0.006
  93. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure. Cardiovasc Drugs Ther. 2025 06; 39(3):553-562.
    View in: PubMed
    Score: 0.006
  94. Deep learning-based automatic segmentation of cardiac substructures for lung cancers. Radiother Oncol. 2024 02; 191:110061.
    View in: PubMed
    Score: 0.006
  95. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 01 02; 149(1):e1-e156.
    View in: PubMed
    Score: 0.006
  96. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint?Committee?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2024 01 02; 83(1):109-279.
    View in: PubMed
    Score: 0.006
  97. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. N Engl J Med. 2003 Nov 13; 349(20):1963-5.
    View in: PubMed
    Score: 0.005
  98. Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res. 2023 11 01; 29(21):4430-4440.
    View in: PubMed
    Score: 0.005
  99. SGLT2 Inhibitor Use and Risk of Clinical?Events in Patients With Cancer Therapy-Related Cardiac Dysfunction. JACC Heart Fail. 2024 01; 12(1):67-78.
    View in: PubMed
    Score: 0.005
  100. Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.
    View in: PubMed
    Score: 0.005
  101. Optimizing Background Therapy for?Heart?Failure in Clinical Trials: Towards a More Objective Approach. JACC Heart Fail. 2023 07; 11(7):806-809.
    View in: PubMed
    Score: 0.005
  102. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2023 Nov; 166(5):e182-e331.
    View in: PubMed
    Score: 0.005
  103. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 05 09; 81(18):1835-1878.
    View in: PubMed
    Score: 0.005
  104. Perils of the random experiment. Am J Ther. 2003 Mar-Apr; 10(2):112-21.
    View in: PubMed
    Score: 0.005
  105. Kinase Inhibitors and Atrial Fibrillation: Mechanisms of Action and Clinical Implications. JACC Clin Electrophysiol. 2023 04; 9(4):591-602.
    View in: PubMed
    Score: 0.005
  106. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support. J Card Fail. 2023 03; 29(3):304-374.
    View in: PubMed
    Score: 0.005
  107. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support. J Heart Lung Transplant. 2023 04; 42(4):e1-e64.
    View in: PubMed
    Score: 0.005
  108. Advances in Multimodality Imaging in?Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 10 18; 80(16):1560-1578.
    View in: PubMed
    Score: 0.005
  109. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer. 2022 12; 177:197-205.
    View in: PubMed
    Score: 0.005
  110. The fragility of cardiovascular clinical trial results. J Card Fail. 2002 Aug; 8(4):247-53.
    View in: PubMed
    Score: 0.005
  111. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer? Curr Atheroscler Rep. 2022 08; 24(8):599-606.
    View in: PubMed
    Score: 0.005
  112. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Arch Cardiovasc Dis. 2022 May; 115(5):315-330.
    View in: PubMed
    Score: 0.005
  113. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e895-e1032.
    View in: PubMed
    Score: 0.005
  114. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e876-e894.
    View in: PubMed
    Score: 0.005
  115. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary. J Card Fail. 2022 05; 28(5):810-830.
    View in: PubMed
    Score: 0.005
  116. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):e263-e421.
    View in: PubMed
    Score: 0.005
  117. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):1757-1780.
    View in: PubMed
    Score: 0.005
  118. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
    View in: PubMed
    Score: 0.005
  119. Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep. 2022 05; 24(5):543-553.
    View in: PubMed
    Score: 0.005
  120. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis. Am J Hematol. 2022 04; 97(4):411-420.
    View in: PubMed
    Score: 0.005
  121. Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure. Heart Fail Monit. 2002; 3(2):42-8.
    View in: PubMed
    Score: 0.005
  122. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart. 2021 12; 8(2).
    View in: PubMed
    Score: 0.005
  123. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol. 2021 11 01; 6(11):1329-1337.
    View in: PubMed
    Score: 0.005
  124. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2021 11 02; 144(18):1521-1523.
    View in: PubMed
    Score: 0.005
  125. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol. 2021 11; 47:102132.
    View in: PubMed
    Score: 0.005
  126. Anemia in Cardiovascular Disease: Marker of Disease Severity or Disease-modifying Therapeutic Target? Curr Atheroscler Rep. 2021 08 10; 23(10):61.
    View in: PubMed
    Score: 0.005
  127. Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. Chest. 2001 Aug; 120(2):453-9.
    View in: PubMed
    Score: 0.005
  128. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. 2021 10; 23(10):1725-1735.
    View in: PubMed
    Score: 0.005
  129. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021 Aug; 162(2):e183-e353.
    View in: PubMed
    Score: 0.005
  130. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst. 2021 05 04; 113(5):513-522.
    View in: PubMed
    Score: 0.005
  131. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021 Jul; 162(1):e23-e106.
    View in: PubMed
    Score: 0.005
  132. Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA. Cardiology. 2021; 146(4):481-488.
    View in: PubMed
    Score: 0.005
  133. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001 Apr 24; 103(16):2055-9.
    View in: PubMed
    Score: 0.005
  134. Cardiovascular Toxicities of Androgen Deprivation Therapy. Curr Treat Options Oncol. 2021 04 17; 22(6):47.
    View in: PubMed
    Score: 0.005
  135. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol. 2021 05; 73(5):866-874.
    View in: PubMed
    Score: 0.005
  136. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev. 2001 Mar; 6(2):143-51.
    View in: PubMed
    Score: 0.005
  137. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol. 2021 03 01; 36(2):234-240.
    View in: PubMed
    Score: 0.005
  138. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.005
  139. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 12 22; 142(25):e558-e631.
    View in: PubMed
    Score: 0.004
  140. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 12 22; 142(25):e533-e557.
    View in: PubMed
    Score: 0.004
  141. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 12 22; 76(25):3022-3055.
    View in: PubMed
    Score: 0.004
  142. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 12 22; 76(25):e159-e240.
    View in: PubMed
    Score: 0.004
  143. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy. 2020; 65(3-4):65-76.
    View in: PubMed
    Score: 0.004
  144. Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study. J Am Heart Assoc. 2020 10 20; 9(19):e014669.
    View in: PubMed
    Score: 0.004
  145. Home Health Care Use and Post-Discharge Outcomes After Heart?Failure Hospitalizations. JACC Heart Fail. 2020 12; 8(12):1038-1049.
    View in: PubMed
    Score: 0.004
  146. Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol. 2020 10; 15(10):1682-1690.
    View in: PubMed
    Score: 0.004
  147. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol. 2020 08 15; 313:1-8.
    View in: PubMed
    Score: 0.004
  148. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 03; 13(3):e006513.
    View in: PubMed
    Score: 0.004
  149. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.004
  150. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.004
  151. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019 08 13; 140(7):e294-e324.
    View in: PubMed
    Score: 0.004
  152. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. J Card Fail. 2019 Aug; 25(8):584-619.
    View in: PubMed
    Score: 0.004
  153. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.004
  154. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
    View in: PubMed
    Score: 0.004
  155. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol. 2019 07 15; 124(2):296-302.
    View in: PubMed
    Score: 0.004
  156. Recent Innovations, Modifications,?and?Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our?Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical?Practice?Guidelines. J Am Coll Cardiol. 2019 Apr 23; 73(15):1990-1998.
    View in: PubMed
    Score: 0.004
  157. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019 May; 25(5):380-400.
    View in: PubMed
    Score: 0.004
  158. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.004
  159. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.004
  160. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45.
    View in: PubMed
    Score: 0.004
  161. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.004
  162. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
    View in: PubMed
    Score: 0.004
  163. De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
    View in: PubMed
    Score: 0.004
  164. Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults. J Am Coll Cardiol. 2018 06 05; 71(22):2527-2536.
    View in: PubMed
    Score: 0.004
  165. Prevention of "Failure": Is It a Failure of Prevention? Circulation. 2018 01 09; 137(2):106-108.
    View in: PubMed
    Score: 0.004
  166. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
    View in: PubMed
    Score: 0.004
  167. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol. 2017 06 15; 119(12):2030-2034.
    View in: PubMed
    Score: 0.003
  168. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e579-e646.
    View in: PubMed
    Score: 0.003
  169. Cardiac involvement in scleroderma. Rheum Dis Clin North Am. 1996 Nov; 22(4):841-60.
    View in: PubMed
    Score: 0.003
  170. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
    View in: PubMed
    Score: 0.003
  171. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail. 2016 08; 9(8).
    View in: PubMed
    Score: 0.003
  172. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
    View in: PubMed
    Score: 0.003
  173. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
    View in: PubMed
    Score: 0.003
  174. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8.
    View in: PubMed
    Score: 0.003
  175. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812.
    View in: PubMed
    Score: 0.003
  176. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail. 2015 Nov; 8(6):1052-8.
    View in: PubMed
    Score: 0.003
  177. Response to Letter Regarding Article, ?Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction?. Circ Heart Fail. 2015 Jul; 8(4):840.
    View in: PubMed
    Score: 0.003
  178. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.
    View in: PubMed
    Score: 0.003
  179. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail. 2015 May; 8(3):533-41.
    View in: PubMed
    Score: 0.003
  180. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
    View in: PubMed
    Score: 0.003
  181. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
    View in: PubMed
    Score: 0.003
  182. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015 Mar; 8(2):384-409.
    View in: PubMed
    Score: 0.003
  183. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J. 2015 Apr 14; 36(15):939-45.
    View in: PubMed
    Score: 0.003
  184. Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):53-8.
    View in: PubMed
    Score: 0.003
  185. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6.
    View in: PubMed
    Score: 0.003
  186. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
    View in: PubMed
    Score: 0.003
  187. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014 Aug; 2(4):412-21.
    View in: PubMed
    Score: 0.003
  188. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2014 Mar 01; 172(1):239-41.
    View in: PubMed
    Score: 0.003
  189. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.
    View in: PubMed
    Score: 0.003
  190. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014 Jan; 7(1):123-30.
    View in: PubMed
    Score: 0.003
  191. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther. 2013 Oct; 31(5):291-7.
    View in: PubMed
    Score: 0.003
  192. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
    View in: PubMed
    Score: 0.003
  193. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013 Oct 09; 168(4):3741-6.
    View in: PubMed
    Score: 0.003
  194. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013 Mar 27; 309(12):1268-77.
    View in: PubMed
    Score: 0.003
  195. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012 Dec 13; 367(24):2296-304.
    View in: PubMed
    Score: 0.003
  196. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J. 2012 Nov; 164(5):763-770.e3.
    View in: PubMed
    Score: 0.003
  197. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct; 18(10):792-8.
    View in: PubMed
    Score: 0.003
  198. PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail. 2012 Sep 01; 5(5):653-9.
    View in: PubMed
    Score: 0.003
  199. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.002
  200. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail. 2012 Mar; 18(3):176-82.
    View in: PubMed
    Score: 0.002
  201. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail. 2012 Mar 01; 5(2):152-9.
    View in: PubMed
    Score: 0.002
  202. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.002
  203. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013 Jun 20; 166(2):394-8.
    View in: PubMed
    Score: 0.002
  204. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
    View in: PubMed
    Score: 0.002
  205. New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail. 2011 Jul; 4(4):456-62.
    View in: PubMed
    Score: 0.002
  206. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 03; 364(9):797-805.
    View in: PubMed
    Score: 0.002
  207. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.002
  208. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol. 2010 Oct 01; 172(7):781-9.
    View in: PubMed
    Score: 0.002
  209. Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag. 2010 Aug 09; 6:449-55.
    View in: PubMed
    Score: 0.002
  210. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.002
  211. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.002
  212. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
    View in: PubMed
    Score: 0.002
  213. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.002
  214. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg. 2008 Nov; 196(5):720-5.
    View in: PubMed
    Score: 0.002
  215. Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail. 2008 Aug; 14(6):489-96.
    View in: PubMed
    Score: 0.002
  216. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.002
  217. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol. 2008 Jan 29; 51(4):415-26.
    View in: PubMed
    Score: 0.002
  218. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest. 2003 Mar; 123(3):716-24.
    View in: PubMed
    Score: 0.001
  219. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
    View in: PubMed
    Score: 0.001
  220. New therapeutics for chronic heart failure. Annu Rev Med. 2002; 53:59-74.
    View in: PubMed
    Score: 0.001
  221. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments. Control Clin Trials. 2001 Dec; 22(6):605-19.
    View in: PubMed
    Score: 0.001
  222. Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit. 2001; 1(4):114-21.
    View in: PubMed
    Score: 0.001
  223. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 1999 May; 14(3):206-10.
    View in: PubMed
    Score: 0.001
  224. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. Am J Cardiol. 1998 Mar 01; 81(5):615-23.
    View in: PubMed
    Score: 0.001
  225. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol. 1997 May; 12(3):218-23.
    View in: PubMed
    Score: 0.001
  226. Safe use of clonidine, nifedipine and vitamin K in hepatic porphyria. J Assoc Physicians India. 1988 Nov; 36(11):675-6.
    View in: PubMed
    Score: 0.000
  227. Ranitidine and acute intermittent porphyria. J Assoc Physicians India. 1988 Apr; 36(4):295-6.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.